Back to News
Market Impact: 0.05

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Source: globenewswire.com

Management & Governance
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

CEO Michael Halstead will participate in a fireside chat on September 14, 2026, at 9:00 a.m. EDT. The announcement provides no financial results, operational update, or guidance change.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News